Jens Karl Woehlbier

Jens Karl Woehlbier

Director Director DIN 08636876
DIN 08636876 First appointment Jan 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Jens Karl Woehlbier

Data last updated:

Jens Karl Woehlbier has 6 years in corporate governance. Formerly with 1 company, such as Koerber Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08636876
Primary Designation Director
First Appointment 24 Jan 2020
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Koerber Pharma Private Limited U74999MH2018FTC307130
Director24 Jan 20202018₹70.70 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Koerber Pharma Private Limited
Premium access

Shareholding and investment profile for Jens Karl Woehlbier

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jens Karl Woehlbier

Jens Karl Woehlbier has 6 years in corporate governance. Formerly with 1 company, such as Koerber Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Jens Karl Woehlbier has expertise in General Business.

Jens Karl Woehlbier has 6 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available